Stay updated on HERV-W Antagonist GNbAC1 Clinical Trial
Sign up to get notified when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.

Latest updates to the HERV-W Antagonist GNbAC1 Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows a 403 Forbidden error with the site's header and navigation intact. Substantive trial metadata and related terms have been removed, making the study information inaccessible on this record.SummaryDifference16%

- Check36 days agoChange DetectedA funding line '2015 ( U.S. NIH Grant/Contract )' was added to the study record, and the revision history was updated to 'Revision: v3.6.6' (replacing v3.6.5).SummaryDifference0.1%

- Check57 days agoChange DetectedThe site revision has been updated to v3.6.5, replacing the previous v3.6.4, indicating a routine update with no visible changes to the study details.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision on the page updated from v3.6.3 to v3.6.4, indicating a minor platform update. This change does not modify study details, eligibility criteria, or results.SummaryDifference0.1%

- Check93 days agoChange DetectedThe revision tag on the page was updated to v3.6.3, signaling a new revision of the study record.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.6.2 is now displayed in place of v3.6.0, indicating a software/UI update for the study page. The change does not affect study data or eligibility information.SummaryDifference0.1%

Stay in the know with updates to HERV-W Antagonist GNbAC1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HERV-W Antagonist GNbAC1 Clinical Trial page.